Emotion suppression differentially moderates the link between stress and cardiovascular disease risk in Japanese and Americans DOI Creative Commons

Darcianne K. Watanabe,

Shinobu Kitayama, DeWayne P. Williams

et al.

International Journal of Clinical and Health Psychology, Journal Year: 2025, Volume and Issue: 25(1), P. 100555 - 100555

Published: Jan. 1, 2025

Language: Английский

Racial Differences in the Cholesterol-Lowering Effect of Statin DOI Open Access

Ryo Naito,

Katsumi Miyauchi, Hiroyuki Daida

et al.

Journal of Atherosclerosis and Thrombosis, Journal Year: 2016, Volume and Issue: 24(1), P. 19 - 25

Published: Oct. 11, 2016

Statin treatment to reduce low-density lipoprotein cholesterol (LDL-C) is associated with the prevention of cardiovascular events in Western patients. Similar results have been reported studies conducted Japan. However, dose statins and degree LDL-C reduction achieved are different between Asian In addition, there limited data regarding racial differences response statins. this review, Asians Westerners described.

Language: Английский

Citations

105

Postnuclear disaster evacuation and chronic health in adults in Fukushima, Japan: a long-term retrospective analysis DOI Creative Commons
Shuhei Nomura, Marta Blangiardo, Masaharu Tsubokura

et al.

BMJ Open, Journal Year: 2016, Volume and Issue: 6(2), P. e010080 - e010080

Published: Feb. 1, 2016

Objective Japan's 2011 Fukushima Daiichi Nuclear Power Plant incident required the evacuation of over a million people, creating large displaced population with potentially increased vulnerability in terms chronic health conditions. We assessed long-term impact on diabetes, hyperlipidaemia and hypertension. Participants considered participants annual public check-ups from 2008 to 2014, administrated by Minamisoma City Soma City, located about 10–50 km nuclear plant. Methods Disease risks, measured pre-incident post-incident relative were examined compared between evacuees non-evacuees/temporary-evacuees. also constructed logistic regression models assess disease risks adjusted for covariates. Results Data total 6406 individuals aged 40–74 years who participated both at baseline (2008–2010) one or more analysed. Regardless evacuation, significant increases risk observed diabetes (relative risk: 1.27–1.60 1.12–1.30, respectively, depending status year). After adjustment covariates, increase was significantly greater among than non-evacuees/temporary-evacuees (OR 1.18, 95% CI 1.06 1.32, p<0.01). Conclusions The singularity this study is that following disaster found be associated small adults. Our findings help identify discussion points planning, including preparedness, response recovery measures, applicable future disasters requiring mass evacuation.

Language: Английский

Citations

89

PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets DOI Creative Commons
Yi Zheng, Mingyan Shao, Yanfei Zheng

et al.

Journal of Advanced Research, Journal Year: 2024, Volume and Issue: unknown

Published: March 1, 2024

Atherosclerosis is a chronic and complex disease caused by lipid disorder, inflammation, other factors. It closely related to cardiovascular diseases, the chief cause of death globally. Peroxisome proliferator-activated receptors (PPARs) are valuable anti-atherosclerosis targets that showcase multiple roles at different pathological stages atherosclerosis for cell types tissue sites. Aim Review: Considering spatial temporal characteristics evolution atherosclerosis, pharmacological clinical studies PPARs were summarized systematically updated under in vascular cells atherosclerosis. Moreover, selective PPAR modulators PPAR-pan agonists can exert their synergistic effects meanwhile reducing side effects, thereby providing novel insight into future drug development precise spatial–temporal therapeutic strategy targeting PPARs. Key Scientific Concepts Based on we have proposed importance stage- type-dependent precision therapy. Initially, improve endothelial cells' dysfunction inhibiting inflammation oxidative stress then regulate macrophages' metabolism polarization fatty streak. Finally, reduce fibrous cap formation suppressing proliferation migration smooth muscle (VSMCs). Therefore, research type-specific mechanisms provide foundation space–time treatment. demonstrated several drugs or compounds activation Selective (that specifically activate gene subsets PPARs) cell-specific effects. Furthermore, dual- pan-PPAR agonist could perform better role balancing efficacy cells/tissue-specific basis therapy

Language: Английский

Citations

9

Obicetrapib as an Adjunct to Stable Statin Therapy in Japanese Subjects: Results from a Randomized Phase 2 Trial DOI Open Access
Mariko Harada‐Shiba,

Michael H. Davdison,

Marc Ditmarsch

et al.

Journal of Atherosclerosis and Thrombosis, Journal Year: 2024, Volume and Issue: unknown

Published: Jan. 1, 2024

Aims: Obicetrapib is a highly selective cholesteryl ester transfer protein (CETP) inhibitor shown to reduce low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB), when taken as monotherapy in combination with ezetimibe on background of statins, clinical trials predominantly conducted Northern European/Caucasian participants. We characterized the efficacy, safety, tolerability obicetrapib within an Asian-Pacific region population.

Language: Английский

Citations

9

A Comprehensive Analysis of Diabetic Complications and Advances in Management Strategies DOI Open Access
Hitoshi Iwasaki, Hiroaki Yagyu, Hitoshi Shimano

et al.

Journal of Atherosclerosis and Thrombosis, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Diabetes mellitus, particularly type 2 diabetes mellitus (T2DM), is a pervasive chronic disease that affects millions of people worldwide. It predisposes individuals to range severe microvascular and macrovascular complications, which drastically impact the patient's quality life increase mortality rates owing various comorbidities. This extensive review explores intricate pathophysiology underlying diabetic focusing on key mechanisms, such as atherosclerosis, insulin resistance, inflammation, endothelial dysfunction. also highlights recent therapeutic advancements, including introduction SGLT2 inhibitors GLP-1 receptor agonists, provide benefits beyond glycemic control offer cardiovascular renal protection. Furthermore, future position agonists in terms prevention diseases will be discussed. Considering differences secretion capacity between Western Asian patients, Japanese we propose treatment strategy for high-quality Japan.

Language: Английский

Citations

1

Impact of an Intensive Lipid-Lowering Therapy Protocol on Achieving Target Low-Density Lipoprotein Cholesterol Levels in Patients With Acute Coronary Syndrome DOI Open Access

Kosuke Seiyama,

Akihiro Oka, Toru Miyoshi

et al.

Circulation Reports, Journal Year: 2025, Volume and Issue: 7(2), P. 131 - 138

Published: Jan. 10, 2025

Background: Intensive lipid-lowering therapy (ILLT) is crucial for preventing secondary acute coronary syndrome (ACS). However, achieving target low-density lipoprotein cholesterol (LDL-C) levels remains challenging in clinical practice.

Language: Английский

Citations

1

Clinical Significance of Serum Omega-3 Fatty Acids on Endothelial Function in Patients with Coronary Artery Disease Under Statin Therapy DOI Creative Commons
Kei Yunoki,

Hiroaki Matsumi,

Toru Miyoshi

et al.

Journal of Cardiovascular Development and Disease, Journal Year: 2025, Volume and Issue: 12(2), P. 60 - 60

Published: Feb. 5, 2025

Vascular endothelial function plays an important role in the pathogenesis of atherosclerosis. The reduction low-density lipoprotein cholesterol (LDL-C) is a key therapy for preventing coronary artery disease (CAD), but omega-3 fatty acids as residual risk factors CAD remains controversial. We studied correlation between serum acid levels and patients with receiving statin examined effect eicosapentaenoic (EPA) on function. A total 150 consecutive (LDL-C < 100 mg/dL) were enrolled. Serum measured, was assessed by flow-mediated dilation (FMD) brachial artery. Subsequently, 65 impaired FMD (<6%) low EPA/arachidonic (AA) (<0.3) administered EPA, reassessed after 3 months. multivariate linear regression analysis demonstrated that docosahexaenoic (DHA) EPA plus DHA independent determinants %FMD (β = 0.214 0.163, p 0.05, respectively). significantly improved (from 3.7 ± 1.0% to 4.1 1.0%, 0.05) EPA/AA, especially EPA/AA high triglyceride 3.4 4.0 1.1%, 0.01). associated dysfunction therapy. improves those triglycerides.

Language: Английский

Citations

1

Efficacy and Safety of Bempedoic Acid for Hypercholesterolemia in Japan: A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Trial DOI Open Access
Shizuya Yamashita, Hitomi Fujita,

Daisuke Yokota

et al.

Journal of Atherosclerosis and Thrombosis, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

We evaluated the efficacy and safety of bempedoic acid, an ATP-citrate lyase inhibitor, at doses 60, 120, 180 mg, administered for 12 weeks in conjunction with ongoing treatments (e.g., statin and/or other lipid-modifying therapy) determined phase 3 trial dosage Japanese patients. This multicenter, randomized, double-blind, placebo-controlled, parallel-group, 2b included patients hypercholesterolemia risk cardiovascular events inadequate response to statins/statin intolerance. The percentage change low-density lipoprotein cholesterol (LDL-C) from baseline week was calculated. acid 60 120 placebo groups 47, 46, 48, 47 patients, respectively; 79% had statins 21% Relative (-1.9%), LDL-C reduction significantly greater treatment (least squares mean: -10.6%; -21.9%; -21.3%; p<0.01 vs. placebo). Patients intolerance who were treated showed improved levels by 12. incidence treatment-emergent adverse higher acid-treated (60 57.4%; 54.3%; 58.3%) than group (38.3%). There no increasing trend doses. Adverse related muscular hepatic disorders infrequent, new or worsening cases diabetes reported. elevated confirmed. mg found be appropriate a trial.

Language: Английский

Citations

1

Long-term association of vegetable and fruit intake with risk of dementia in Japanese older adults: the Hisayama study DOI Creative Commons
Yasumi Kimura, Daigo Yoshida, Tomoyuki Ohara

et al.

BMC Geriatrics, Journal Year: 2022, Volume and Issue: 22(1)

Published: March 28, 2022

Abstract Background Several prospective Western studies have reported an inverse association of vegetable and fruit intake with dementia risk. However, there is limited epidemiologic evidence in Asians. This study investigated the intakes vegetables, fruits, their nutrients on risk incident its subtypes a Japanese community. Methods A total 1071 participants (452 men 619 women) aged ≥60 years without at baseline were prospectively followed up for 24 years. Intakes evaluated using 70-item semiquantitative food frequency questionnaire categorized into quartiles separately by gender. The outcome measure was development subtypes—namely, Alzheimer’s disease (AD) vascular (VaD). estimates computed Cox proportional hazards model. Results During long-term follow-up period, 464 subjects developed dementia, whom 286 had AD 144 VaD. Higher associated gradually lower developing (both P -trend < 0.05), but not VaD, after adjusting confounders. Subjects allocated highest quartile 27 31% AD, respectively, than those lowest quartile. decreased significantly higher vitamin A, riboflavin, C, magnesium, calcium, potassium (all 0.05). dietary fiber tended to be ( = 0.07). Meanwhile, no significant associations between subtypes. Conclusion vegetables constituent older adults. diet rich may beneficial reducing

Language: Английский

Citations

28

JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease DOI Open Access
Akira Fujiyoshi, Shun Kohsaka, Jun Hata

et al.

Circulation Journal, Journal Year: 2024, Volume and Issue: 88(5), P. 763 - 842

Published: March 12, 2024

8CQ: Is comprehensive risk assessment using prediction models for the primary prevention of CVD helpful in reducing mortality?

Language: Английский

Citations

6